Pernix Therapeutics Holdings Inc (PTXTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 37,156 | 21,088 | 28,139 | 41,541 | 40,469 |
| Cost of Goods | 11,823 | 5,569 | 8,961 | 13,518 | 10,580 |
| Gross Profit | 25,333 | 15,519 | 19,178 | 28,023 | 29,889 |
| Operating Expenses | 36,683 | 20,527 | 29,205 | 53,283 | 29,455 |
| Operating Income | -10,527 | -4,439 | -9,066 | -24,742 | 1,014 |
| Interest Expense | 10,073 | 9,530 | 9,460 | 9,466 | 9,323 |
| Other Income | -688 | 465 | -19 | 2,036 | 14,696 |
| Pre-tax Income | -21,288 | -13,504 | -18,545 | -32,172 | 6,387 |
| Income Tax | 61 | 9 | 39 | 251 | 27 |
| Net Income Continuous | -21,349 | -13,513 | -18,584 | -32,423 | 6,360 |
| Minority Interests | -9,504 | N/A | N/A | N/A | N/A |
| Net Income | $-11,845 | $-13,513 | $-18,584 | $-32,423 | $6,360 |
| EPS Basic Total Ops | -0.89 | -1.13 | -1.57 | -2.68 | 0.57 |
| EPS Basic Continuous Ops | -1.61 | -1.13 | -1.57 | -2.68 | 0.57 |
| EPS Diluted Total Ops | -0.89 | -1.13 | -1.57 | -2.53 | 0.42 |
| EPS Diluted Continuous Ops | -1.61 | -1.13 | -1.57 | -2.49 | 0.39 |
| EPS Diluted Before Non-Recurring Items | -0.89 | -1.13 | -1.57 | -2.78 | -0.57 |
| EBITDA(a) | $-3,599 | $-759 | $2,983 | $-4,110 | $21,286 |